Skip to content

Analisys of Neuromuscular Response, Postural Balance and Quality of Life of Diabetics Type 2 After Sensory-motor Training: Blind Random Controled Clinical Trial

Analisys of Neuromuscular Response, Postural Balance and Quality of Life of Diabetics Type 2 After Sensory-motor Training: Blind Random Controled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01861392
Enrollment
50
Registered
2013-05-23
Start date
2013-05-31
Completion date
2016-12-31
Last updated
2013-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Exercise Therapy, Postural Balance, Quality of Life

Keywords

postural balance sensory motor trayning physical therapy modalities diabetes mellitus

Brief summary

Background: The individual's ability to sustain itself in the upright position, effectively adjusting the body's movements and reacting to external stimuli, postural control strategies represent essential activities of daily living. Diabetes mellitus type 2 (DM-2) is considered a more problem of Public Health as having complications deficit in functional performance of the lower limbs and falls, which can interfere with the maintenance of balance, and is a strong predictor of functional limitations self referred. Aim: To assess quality of life and the answers neuromuscular balance and baropodometric after sensory-motor training in patients with type 2 diabetes. Method: To be recruited 50 volunteers aged between 45 to 64 years with DM-2, of both sexes, divided into two groups: 1) Guidelines and 2) Guidelines + sensory-motor training. Biomechanical data will be collected (balance, baropodometry, electromyography strength and joint position sense), as well as questionnaires ADDQoL and BESTest. The intervention will be twice a week for 45 minutes for 12 weeks, divided into three phases: heating, sensory-motor training and cool-down, with monitoring of blood pressure and blood glucose. There will be a follow up after 3 months of intervention. Statistical analysis will be used normality test to verify the data distribution and consistent statistical test for the appropriate comparisons within and between groups, and adopted a significance level of 5%. Expected Results: Considering previous studies that demonstrate improvement in postural balance static and dynamic responses under the forward training protocol sensorimotor disease Diabetes mellitus type 2, is expected to improve neuromuscular, balance, distribution plant, the joint position sense and the quality of life of voluntary DM-2. Keywords: physical therapy modalities, exercise therapy, postural balance, Diabetes Mellitus, quality of life.

Interventions

PROCEDUREsensorio-motor training

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
45 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of diabetes mellitus type 2 with controlled blood glucose * Absence of skin lesions or fractures of the lower limbs in the last 6 months -Plantar malformations * Severe postural abnormalities and limb length difference.

Exclusion criteria

* Use of medications that can have negative effects on the function of cognition, attention and psychomotor (ie, opioids, antiepileptics, anxiolytics, antipsychotics, hypnotics and sedatives) * Diagnosis of cardiovascular, neurological, rheumatological and musculoskeletal disorders that may interfere with activities of daily living * Presence of vestibular disorders

Design outcomes

Primary

MeasureTime frame
Postural balance training diabetic type 2four years

Secondary

MeasureTime frame
Quality of life of diabetics type 2four years

Countries

Brazil

Contacts

Primary ContactAriane H.M Pletsch, PHD student
ariane_mansano@usp.br+551636020462
Backup ContactRinaldo Roberto Jesus Guirro, PHD
rguirro@fmrp.usp.br+551636024584

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026